Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease
Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (12) · 1703-1704
DOI: 10.1111/apt.70700 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-04-25. Written by Jiacheng Li. Institution: Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China. Cited 1 times so far (Crossref); 5 references.
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
ORCID profiles: Jiacheng Li
Cite
APA
Li, J. (2026). Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Alimentary Pharmacology & Therapeutics, 63(12), 1703-1704. https://doi.org/10.1111/apt.70700
Vancouver
Li J. Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Alimentary Pharmacology & Therapeutics. 2026;63(12):1703-1704. doi:10.1111/apt.70700
BibTeX
@article{Li2026,
author = {Li, Jiacheng},
title = {Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {12},
pages = {1703--1704},
doi = {10.1111/apt.70700}
}
EUVIMED